Efficacy and safety of recombinant human erythropoietin (Hema-Plus(®)) for management of anemia in Thai patients on peritoneal dialysis

BACKGROUND: Hema-Plus, a recombinant human erythropoietin (rHuEPO) or epoetin alfa has shown effectiveness in correction of anemia in Thai population in clinical practice. This study was aimed to demonstrate efficacy and safety under the evidence-based approach. AIM: To evaluate the efficacy and saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuengsaman, Piyatida, Narenpitak, Surapong, Sritippayawan, Suchai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641037/
https://www.ncbi.nlm.nih.gov/pubmed/34909408
http://dx.doi.org/10.5527/wjn.v10.i6.109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641037/
https://www.ncbi.nlm.nih.gov/pubmed/34909408
http://dx.doi.org/10.5527/wjn.v10.i6.109

Ejemplares similares